354 related articles for article (PubMed ID: 34150624)
1. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.
Hipólito A; Martins F; Mendes C; Lopes-Coelho F; Serpa J
Front Oncol; 2021; 11():656851. PubMed ID: 34150624
[TBL] [Abstract][Full Text] [Related]
2. Tumor metastasis: Mechanistic insights and therapeutic interventions.
Liu M; Yang J; Xu B; Zhang X
MedComm (2020); 2021 Dec; 2(4):587-617. PubMed ID: 34977870
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Potential of Cancer Cells in Context of the Metastatic Cascade.
Benzarti M; Delbrouck C; Neises L; Kiweler N; Meiser J
Cells; 2020 Sep; 9(9):. PubMed ID: 32899554
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of prostate cancer metastasis.
Rycaj K; Tang DG
Oncotarget; 2017 Oct; 8(50):88211-88231. PubMed ID: 29152153
[TBL] [Abstract][Full Text] [Related]
5. Decoding the interplay between genetic and non-genetic drivers of metastasis.
Karras P; Black JRM; McGranahan N; Marine JC
Nature; 2024 May; 629(8012):543-554. PubMed ID: 38750233
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of breast cancer metastasis.
Thakur C; Qiu Y; Pawar A; Chen F
Cancer Metastasis Rev; 2024 Jun; 43(2):597-619. PubMed ID: 37857941
[TBL] [Abstract][Full Text] [Related]
7. Emerging insights into the biology of metastasis: A review article.
Irani S
Iran J Basic Med Sci; 2019 Aug; 22(8):833-847. PubMed ID: 31579438
[TBL] [Abstract][Full Text] [Related]
8. Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.
Gao D; Li S
Cancer Microenviron; 2013 Dec; 6(3):213-30. PubMed ID: 24214411
[TBL] [Abstract][Full Text] [Related]
9. Lipids as mediators of cancer progression and metastasis.
Vogel FCE; Chaves-Filho AB; Schulze A
Nat Cancer; 2024 Jan; 5(1):16-29. PubMed ID: 38273023
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy.
Chaube B; Malvi P
Front Oncol; 2023; 13():1289397. PubMed ID: 37799477
[No Abstract] [Full Text] [Related]
11. Correction: Reprogramming anchorage dependency by adherent‑to‑suspension transition promotes metastatic dissemination.
Huh HD; Sub Y; Oh J; Kim YE; Lee JY; Kim HR; Lee S; Lee H; Pak S; Amos SE; Vahala D; Park JH; Shin JE; Park SY; Kim HS; Roh YH; Lee HW; Guan KL; Choi YS; Jeong J; Choi J; Roe JS; Gee HY; Park HW
Mol Cancer; 2023 Aug; 22(1):135. PubMed ID: 37580748
[No Abstract] [Full Text] [Related]
12. PI3K signaling-regulated metabolic reprogramming: From mechanism to application.
Su WY; Tian LY; Guo LP; Huang LQ; Gao WY
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188952. PubMed ID: 37499988
[TBL] [Abstract][Full Text] [Related]
13. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.
Malayil R; Chhichholiya Y; Vasudeva K; Singh HV; Singh T; Singh S; Munshi A
Med Oncol; 2023 May; 40(6):174. PubMed ID: 37170010
[TBL] [Abstract][Full Text] [Related]
15. Amino acid metabolic reprogramming in tumor metastatic colonization.
Wang Z; Wu X; Chen HN; Wang K
Front Oncol; 2023; 13():1123192. PubMed ID: 36998464
[TBL] [Abstract][Full Text] [Related]
16. Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment.
Benito-Lopez JJ; Marroquin-Muciño M; Perez-Medina M; Chavez-Dominguez R; Aguilar-Cazares D; Galicia-Velasco M; Lopez-Gonzalez JS
Front Oncol; 2022; 12():1101503. PubMed ID: 36713558
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Metabolic reprogramming in breast cancer.
Scatena C; Naccarato AG; Ozsvari B; Scumaci D
Front Oncol; 2022; 12():1081171. PubMed ID: 36439453
[No Abstract] [Full Text] [Related]
18. PD-L1 Activity Is Associated with Partial EMT and Metabolic Reprogramming in Carcinomas.
Muralidharan S; Sehgal M; Soundharya R; Mandal S; Majumdar SS; Yeshwanth M; Saha A; Jolly MK
Curr Oncol; 2022 Oct; 29(11):8285-8301. PubMed ID: 36354714
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
